Best Brukinsa (Zanubrutinib) Medicine in India

Brukinsa (Zanubrutinib) is a targeted anticancer medicine used to treat certain types of blood cancers, including mantle cell lymphoma, Waldenström's macroglobulinemia, and marginal zone lymphoma in eligible patients. It belongs to a group of medicines called Bruton’s tyrosine kinase (BTK) inhibitors and works by blocking signals that help abnormal B-cells grow and survive.

Brukinsa (Zanubrutinib) should be taken exactly as prescribed by your doctor. The dose and treatment duration depend on your type of cancer, overall health, and response to treatment. It may be taken with or without food. Regular medical check-ups and blood tests may be required to monitor your blood counts, liver function, and treatment response.

Common side effects of Brukinsa (Zanubrutinib) may include low blood cell counts, infections, bruising, bleeding, diarrhea, constipation, fatigue, muscle or joint pain, cough, and skin rash. Inform your doctor if any side effect becomes severe, persists, or causes concern. Before starting treatment, tell your doctor about your medical conditions and all medicines, vitamins, herbal products, or dietary supplements you are taking.

Treatment of Blood Cancers

Brukinsa (Zanubrutinib) is used to treat certain B-cell blood cancers, including mantle cell lymphoma, Waldenström's macroglobulinemia, and marginal zone lymphoma in eligible patients. It works by blocking Bruton’s tyrosine kinase (BTK), a protein involved in the growth and survival of abnormal B-cells. By reducing these signals, Zanubrutinib helps slow the growth and spread of cancer cells and may help control disease progression.

Some side effects of Brukinsa (Zanubrutinib) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Brukinsa (Zanubrutinib)

Brukinsa (Zanubrutinib) should be taken exactly as prescribed by your doctor. It may be taken with or without food. Swallow it whole with water and do not crush, chew, or break it. Take the prescribed dose regularly and do not change or stop treatment without consulting your doctor.

Brukinsa (Zanubrutinib) works by blocking Bruton’s tyrosine kinase (BTK), a protein that plays an important role in the growth and survival of abnormal B-cells. By inhibiting BTK signaling, Zanubrutinib helps prevent cancer cells from growing and surviving, which may slow the progression of certain B-cell blood cancers.

• Keep the medicine at room temperature between 20°C and 25°C, away from excessive heat and moisture.
• Store it in a dry, secure place where children and pets cannot reach it.
• Keep the medicine in its original container and close it properly after use.
• Avoid storing the medicine in direct sunlight or near sources of heat.

Alcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Brukinsa (Zanubrutinib), as it may increase certain side effects.

Pregnancy CONSULT YOUR DOCTOR

Brukinsa (Zanubrutinib) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant.

Breastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Brukinsa (Zanubrutinib). Consult your doctor for guidance.

Driving CONSULT YOUR DOCTOR

Brukinsa (Zanubrutinib) may cause fatigue or dizziness. Avoid driving if these symptoms affect your alertness.

Kidney CAUTION

Inform your doctor if you have kidney problems before starting Brukinsa (Zanubrutinib). Your doctor may monitor your kidney function during treatment.

Liver CAUTION

Tell your doctor if you have liver disease, as dose adjustment or closer monitoring may be required.

• Take Brukinsa (Zanubrutinib) exactly as prescribed by your doctor and do not change or stop the treatment without medical advice.
• Attend regular blood tests and medical check-ups to monitor your blood counts, liver function, and response to treatment.
• Watch for unusual bruising, bleeding, fever, or signs of infection and contact your doctor promptly if they occur.
• Inform your doctor about all prescription medicines, vitamins, herbal products, and dietary supplements you are taking to help avoid possible drug interactions.
• Avoid activities that may increase the risk of injury if you experience dizziness, weakness, or fatigue during treatment.
• Read More About - Brukinsa (Zanubrutinib) from Pharma Five.

Pharma Five, may assist patients in arranging the import of Brukinsa (Zanubrutinib) in small quantities for personal medical use. The applicant must submit an application in Form 12A along with a prescription from a Registered Medical Practitioner (RMP).

With over two decades of pharmaceutical industry experience, Pharma Five facilitates patient access to Brukinsa (Zanubrutinib) and other specialized pharmaceutical products through professional import-related assistance. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.